Immunity (journal)

Immunity (journal) is a peer-reviewed scientific journal focusing on Immunology and related biomedical research. Founded in 1994 and published by Cell Press, the journal publishes original research articles, reviews, and commentaries that intersect with clinical and basic science topics such as Infectious disease, Autoimmunity, Vaccinology, Tumor immunology, and Transplantation. Immunity serves as a forum for work from laboratories associated with institutions like Harvard University, Massachusetts Institute of Technology, Stanford University, University of Oxford, and Johns Hopkins University.

History

The journal was launched in 1994 by Cell Press during a period of expansion in high-profile biomedical publishing alongside titles such as Cell and Nature Medicine. Early editorial initiatives drew contributors from programs at National Institutes of Health, Salk Institute, Max Planck Society, and leading departments at University of California, San Francisco and Yale University. Over subsequent decades, Immunity navigated shifts in publishing driven by events including the rise of open access advocacy, policies by the National Institutes of Health Public Access Policy, and transformations associated with digital platforms like PubMed Central. Landmark articles in the journal corresponded with major scientific milestones such as work related to HIV/AIDS immunology, discoveries in Toll-like receptor signaling, and developments in CAR T-cell therapy, reflecting the broader trajectory of biomedical research through collaborations with laboratories at Karolinska Institutet, Imperial College London, and the University of Tokyo.

Scope and content

Immunity covers a broad array of topics bridging basic and translational science, including antigen presentation pathways studied in labs at Cold Spring Harbor Laboratory and cytokine biology investigated at Pasteur Institute. The journal's content ranges from mechanistic studies on T cell activation and B cell maturation to translational reports on vaccine efficacy from trials associated with World Health Organization initiatives and clinical centers like Mayo Clinic. Reviews and perspectives often synthesize work connected to signaling cascades such as those involving NF-κB, mTOR, and JAK-STAT pathways produced by researchers affiliated with Weizmann Institute of Science, University of Cambridge, and ETH Zurich. Special issues and commentaries have highlighted intersections with disciplines represented at conferences like the American Association of Immunologists annual meeting and collaborative networks such as the Human Vaccines Project.

Editorial leadership and peer review

Editorial stewardship has involved prominent scientists and administrators with ties to organizations like University of Pennsylvania, Columbia University, and University of Chicago. The editorial model employs in-house editors based at Cell Press's offices in locations linked to publishing hubs such as Boston and San Francisco, working alongside external academic editors drawn from faculties at University of California, Berkeley, University College London, and King's College London. Peer review processes align with standards advocated by bodies like the Committee on Publication Ethics and incorporate double-blind and single-blind review practices, reviewer selection from networks including members of the European Academy of Allergy and Clinical Immunology and the American Association for the Advancement of Science, and editorial decisions that consider compliance with policies from funders such as the Wellcome Trust and the Bill & Melinda Gates Foundation.

Publication and indexing

Published semimonthly by Cell Press, Immunity is available in print and electronic formats distributed through platforms associated with major libraries and consortia like the Library of Congress and the National Library of Medicine. The journal is indexed in major bibliographic databases such as PubMed, Web of Science, Scopus, and Embase, and is tracked by metrics compiled by organizations like Clarivate and Elsevier. Submission guidelines reflect data-sharing expectations exemplified by repositories including Gene Expression Omnibus, Protein Data Bank, and preprint servers akin to bioRxiv. Subscription, licensing, and open-access arrangements have evolved in response to mandates from entities like the European Commission and national research agencies in United Kingdom, Germany, and Australia.

Impact and reception

Immunity is regarded as a high-impact venue within the field alongside journals such as Nature Immunology, Journal of Experimental Medicine, and Cell Host & Microbe. Citation analyses by services like Journal Citation Reports and altmetrics tracked by providers including Altmetric indicate strong influence on fields spanning infectious diseases research, cancer immunotherapy studies pioneered at centers like MD Anderson Cancer Center, and vaccine development programs at institutions such as National Institutes of Health Clinical Center. The journal has received recognition in discussions at forums including panels hosted by Cold Spring Harbor Laboratory and workshops sponsored by the Howard Hughes Medical Institute, while also engaging with debates over reproducibility highlighted by organizations like the National Academy of Sciences.

Category:Immunology journals